NAMIETA MODY JANSSEN (M.D.) – Rheumatology Physician, NPI 1609979947
Rheumatology Physician
Main info
Doctor Profile
Contacts
Profile Insights
NPPES metrics only — not quality of care.
503 RHEUMATOLOGY in TX
Provider Addresses for NAMIETA MODY JANSSEN (M.D.)
1327 LAKE POINTE PKWY STE 535
SUGAR LAND, TX 774784097
Phone: (832) 500-5002
Fax: (832) 500-5011
Type: Mailing
1327 LAKE POINTE PKWY STE 325
SUGAR LAND, TX 774784097
Phone: (832) 500-5002
Fax: (832) 500-5011
Type: Mailing
1327 LAKE POINTE PKWY STE 315
SUGAR LAND, TX 774784553
Phone: (832) 500-5002
Fax: (832) 500-5011
Type: Mailing
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 238 Open Payments records for all available years, with a total value of $97,365.
Total Amount is formed as General ($97,365) + Research ($0) + Ownership ($0) = $97,365.
Last reported payment date: 2024-12-19 • Largest payer in this snapshot: GlaxoSmithKline, LLC. ($45,092).
Total Amount
$97,365
General + Research + Ownership
Payments
238
Total payment records
General Amount
$97,365
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-19
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| GlaxoSmithKline, LLC. | $45,092 |
| Lilly USA, LLC | $40,432 |
| AstraZeneca Pharmaceuticals LP | $4,663 |
| UCB, Inc. | $4,406 |
| Amgen Inc. | $691 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2007-02-01
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20070201000558 | I | Rheumatology | TX | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 178,000 | 37 | $0 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 12,200 | 16 | $0 |
| J0897 | Injection, denosumab, 1 mg | 1,380 | 15 | $0 |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 890 | 37 | $0 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 291 | 39 | $0 |
Insurance plans in this area (ZIP 77478)
Loading plans...
Provider's Procedures
| Specialty | Practice State | HCPCS Code | Description | Service Count | Beneficiary Count |
|---|---|---|---|---|---|
| RHEUMATOLOGY | TX | 96415 | Infusion of chemotherapy into a vein | 195 | 21 |
Group practice members
| Name | Specialty | State |
|---|---|---|
| R H E U M A T O L O G Y | OH |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.